Monday, February 18, 2019

One Step Closer to Precision Medicine Strategies Based on Genetic Information: ABCB1 Polymorphisms in the CHANCE Trial. | Cerebrovascular Disease | JAMA Neurology | JAMA Network

One Step Closer to Precision Medicine Strategies Based on Genetic Information: ABCB1 Polymorphisms in the CHANCE Trial. | Cerebrovascular Disease | JAMA Neurology | JAMA Network



One Step Closer to Precision Medicine Strategies Based on Genetic InformationABCB1 Polymorphisms in the CHANCE Trial

Benjamin P. George, MD, MPH1; Guido J. Falcone, MD, ScD, MPH1
Author Affiliations
JAMA Neurol. Published online February 11, 2019. doi:10.1001/jamaneurol.2018.4404
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)